Linus Health

Big moment at the NYSE!??? ? Yesterday, in collaboration with Fierce Healthcare, the New York Stock Exchange celebrated Linus Health’s inclusion in the Fierce 15 Healthcare list with a full takeover of the historic Trading Floor. ? Fierce Healthcare recently selected Linus Health based on its groundbreaking digital brain health solutions that support earlier detection of MCI and dementia, fast-paced market expansion, and extensive published research with strong clinical validation. ? Read more in the report:?https://lnkd.in/gqGb6Ajf?I #Fierce15 #BrainHealth #HealthcareInnovation #DigitalHealth

Where does Linus Health Chief Strategy Officer Dr. John Showalter see an overlooked opportunity in healthcare? Integrating technology and AI to proactively address brain health, an area he believes is largely neglected in current healthcare strategies. While conditions like heart disease and kidney failure receive significant attention, Dr. Showalter argues that cognitive health is often an afterthought, despite its critical impact on overall well-being. By leveraging AI and digital tools, healthcare can better detect, monitor, and support those with mild cognitive impairment and mood disorders.

We are pleased to announce that we have achieved a major milestone with over 145 peer-reviewed studies conducted and authored by Linus Health and its affiliates. Since 2019, we have: ?? Published 72 peer-reviewed publications? ?? Delivered 75 scientific presentations at academic conferences ?? Completed more than 40 clinical trials and 25 validation studies ?? Filed 33 patents supporting our technology, which is available in 18 languages The majority of the published research features investigations and validations of the efficacy and accuracy of various elements and solutions within our platform designed to promote brain health, detect early indicators of cognitive impairment, and predict the risk of Alzheimer’s disease and other forms of dementia. We are revolutionizing brain health with trusted, science-driven solutions, delivering a comprehensive, end-to-end strategy that supports early detection, intervention, and continuous care across all settings. Read more in today’s press release: https://lnkd.in/g33MjWsG?I #BrainHealth #AlzheimersResearch #DementiaResearch #AlzheimersDisease #MildCognitiveImpairment

We are pleased to announce that Fierce Healthcare has named Linus Health one of 2025’s “Fierce 15” healthcare companies. The annual special report features the most innovative private companies looking to reimagine the face of healthcare. Fierce Healthcare selected Linus Health based on its groundbreaking digital brain health solutions that support earlier detection of MCI and dementia, fast-paced market expansion, and extensive published research with strong clinical validation. Fierce spoke with Linus Health Co-founder & CEO David Bates: “2025 is a year where we see the market really changing and recognizing the importance of brain health.” Bates also shared what Linus will be focusing on in 2025: ?? Expanding its services from healthcare providers and life sciences research to include the managed care market ?? Continuing to integrate AI into the brain health platform in various ways Read more:?https://lnkd.in/gqGb6Ajf?I #Fierce15 #HIMSS25 #BrainHealth #HealthcareInnovation #DigitalHealth

The HIMSS Global Health Conference & Exhibition is less than a week away, and the spotlight is shining on AI. From automating administrative tasks to revolutionizing diagnostics and treatment, AI is set to reshape the healthcare landscape in 2025. HIT Consultant Media spoke with leading healthcare executives and innovators, including Linus Health’s Sean Tobyne, PhD, VP of Data Science and Analytics, to offer a glimpse into the key trends and discussions expected to dominate HIMSS25. “The intersection of health tech and brain health will be a hot topic,” Dr. Tobyne predicts. “AI is helping drive progress in the fight against Alzheimer’s and other dementias. AI-enabled digital tools are making it easier for primary care physicians to detect mild cognitive impairment–a precursor to dementia–earlier to direct these patients towards existing and emerging disease modifying therapies. Personalized treatment plans that leverage large language models and generative AI will allow patients to act to potentially delay the progression of the disease.” Are there any trends you expect to see at this year’s show? Read more of what to expect: https://lnkd.in/e6iGESfh?I #BrainHealth #DigitalHealth #HealthcareInnovation #HIMSS25

Linus Health is a proud sponsor of this year's GAP-Net event, an unparalleled gathering that brings together clinical research leadership, executive teams, and operations colleagues from top Alzheimer's and Parkinson's disease clinical trial sites across North America. Our CEO David Bates had the opportunity to participate in a panel discussion on the potential of blood-based biomarkers and digital assessments in transforming research and clinical practice.

Heading to Las Vegas for HIMSS Global Health Conference & Exhibition next week? So is Linus Health! We're revolutionizing brain health with trusted, science-driven solutions that power an end-to-end brain health strategy. Beyond assessments, we enable earlier detection, intervention, and ongoing care—rooted in research, accessible to all, and tailored for providers across every care setting. Let's connect at HIMSS—message our team to set up a meeting and learn how to elevate your cognitive care. I #HIMSS25 #Dementia #BrainHealth #AlzheimersDisease #HealthcareInnovation #DigitalHealth Curt J. Thornton John Showalter Tim Nash Timothy Russo Greer Trenkner Oscar Torres

In case you missed it, Linus Health Chief Customer Officer & Chief Administrative Officer Leah Ray, CPM,PAHM,PMP was recognized among the Top 50 Women Leaders in Healthcare by The Healthcare Technology Report. Honoring the most innovative female leaders in healthcare technology, Leah was selected for her steadfast leadership and deep expertise in her field, guiding Linus Health through ever-evolving market conditions with an unwavering focus on customer needs in diverse ways. Leah embodies Linus Health’s mission to relentlessly advance early detection and intervention, bringing innovation, compassion, and urgency to one of the most pressing health challenges of our time. Please join us in congratulating Leah! https://lnkd.in/ekJVJKJ2 I #AlzheimersDisease #Dementia #BrainHealth #WomenInHealthTech #HealthcareInnovation

A new Nature Portfolio study reveals that approximately 42% of individuals may develop dementia after age 55, with lifetime risks higher for Black individuals, women, and those with certain genetic markers. The findings underscore the need for targeted public health strategies focused on prevention—particularly through cardiovascular health and hearing preservation—as well as the importance of early detection, which plays a crucial role in managing and mitigating dementia risks. With dementia cases expected to double by 2060, public health policies must prioritize lifestyle interventions and address structural inequalities that contribute to higher risks in minority populations. https://lnkd.in/g73FyTmV I #AlzheimersDisease #Dementia #BrainHealth #Prevention #DementiaResearch #HealthEquity

Is it possible for family caregivers to clearly communicate with a loved one with dementia? While communication strategies vary by disease stage and other factors, Linus Health Chief Strategy Officer Dr. John Showalter and other brain health experts shared their insights with AARP on how to effectively converse with loved ones with dementia: “Meeting a person with dementia ‘in their world’ is acceptable to have a positive interaction as long as everyone is safe. If the hallucinations lead to aggression … get assistance from family, staff in a facility, or even paramedics. Do not argue about the reality of a hallucination with a loved one if it makes them more agitated.” Learn more: https://lnkd.in/gn9yi3uX #Dementia #AlzheimersDisease #BrainHealth #MildCognitiveImpairment